FDG-PET/CT vs. Non-FDG Tracers in Less Explored Domains, An Issue of PET Clinics

Cover image

Title page

Table of Contents

Copyright

Contributors

Forthcoming Issues

CME Accreditation Page

Preface

Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing Misconceptions

Key points

Introduction

2-[18F]fluoro-2-deoxy-D-glucose

Radiolabeled amino acids

Non–amino acid positron emission tomography radiotracers

Discussion

Clinics care points

Disclosure

An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non–Thyroid Endocrine Neoplasms

Key points

Introduction

Fluorodeoxyglucose and non-fluorodeoxyglucose-PET tracers in thyroid neoplasms

Fluorodeoxyglucose and non-fluorodeoxyglucose-PET tracers in parathyroid neoplasms

Fluorodeoxyglucose and non-fluorodeoxyglucose-PET tracers in adrenal neoplasms and tumors of autonomic nervous system

Future directions

Disclosure

18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies

Key points

Introduction

Clinics care points

Summary

Molecular Imaging Assessment of Androgen Deprivation Therapy in Prostate Cancer

Key points

Androgen and prostate cancer

Andogen deprivation therapy and 18F-fluorodeoxyglucose

Androgen deprivation therapy and radiolabeled choline

Androgen deprivation therapy and 18F-fluciclovine

Androgen deprivation therapy and radiolabeled prostate-specific membrane antigen agents

Summary

Clinics care points

Disclosure

Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2-[18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers

Key points

Introduction

2-[18F]-Fluoro-2-deoxy-glucose-PET/computed tomography scans

Estrogen receptor tracer: 16α-[18F]-fluoro-17β-estradiol-PET/computed tomography

Progesterone receptor tracers

Human epidermal growth factor receptor-2 tracers

Other tracers

Summary

Clinics care points

Disclosure

18F-FDG Versus Non-FDG PET Tracers in Multiple Myeloma

Key points

Introduction

Multiple myeloma definition

Epidemiology

Staging

Imaging modalities

Role of PET–computed tomography in monoclonal gammopathy of undetermined significance

Role of PET–computed tomography in smoldering multiple myeloma

Role of PET–computed tomography in solitary plasmacytoma

Role of PET–computed tomography in multiple myeloma

Italian Myeloma Criteria for PET Use

Deauville 5-point scale

Other PET tracers

Summary

Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors

Key points

Introduction

Imaging technique and protocols

Tumor detection and grading

Tumor extent

Treatment response, prognostication, and follow-up

Summary

Clinics care points

Disclosure

Fibroblast Activation Protein Inhibitor Theranostics

Key points

Introduction

Understanding the tumor microenvironment

Molecules targeting fibroblast activation

Evolution of fibroblast activation protein inhibitor radiotracers

Diagnostic studies

Therapeutic studies

Future directions

Summary

Clinics care points

PET-CTBased Quantitative Parameters for Assessment of Treatment Response and Disease Activity in Cancer and Noncancerous Disorders

Key points

Introduction

Summary

Clinics care points

Positron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such Settings

Key points

Introduction

Alzheimer disease

Frontotemporal dementia

Dementia with Lewy bodies

Studies comparing different dementias

Summary

Clinics care points

Nonmalignant Thoracic Disorders: An Appraisal of Fluorodeoxyglucose and Non-fluorodeoxyglucose PET/Computed Tomography Applications

Key points

Introduction

Normal patterns and common pitfalls on PET/computed tomography imaging of the thorax

PET/computed tomography in Non-malignant diseases of the thorax

Future directions

Clinics care points

Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Prosthetic Joints and Diabetic Foot: A Comparative Perspective with Other Functional Imaging Modalities

Key points

Introduction

Imaging of the prosthetic joints

Fluorodeoxyglucose PET/computed tomography for prosthetic joint imaging

Comparison of fluorodeoxyglucose PET/computed tomography with other functional imaging modalities

Comparison of fluorodeoxyglucose PET/computed tomography with other functional imaging modalities

Summary

Clinics care points

Utility of PET/Computed Tomography in Infection and Inflammation Imaging

Key points

Introduction

Disclosure

Clinics care points

Role of Fluorodeoxyglucose-PET in Interventional Radiology

Key points

Introduction

Malignancies

Infectious processes

Inflammatory conditions

Summary

Clinics care points

Conflict of interest